MGI, Dainippon deal

Dainippon received exclusive rights in Japan to the Minneapolis company's acylfulvene compounds, which may aid in the treatment of cancer. MOGN will receive $12 million in milestone payments, $3 million of which are up front. The balance will be paid out over the course of four to four-and-a-half years. ...